Education
About Us
Working with TipRanks
Follow Us
JOHN ABALLI Insider Profile
4 Followers
JOHN ABALLI, President & CEO, Director at Exagen, holds 754.83K shares in Exagen (Ticker: XGN). Most recently, JOHN ABALLI Sold 31,787 shares of Exagen on Oct 20, 2025 for an estimated value of $375.40K.
Profitable Transactions
2 out of 5 Profitable Transactions
Average Return
+92.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
President & CEO, Director
Roles that JOHN ABALLI holds in companies
Most Profitable Insider Trade
The most profitable trade made by JOHN ABALLI
JOHN ABALLI's Trading History
List of latest transactions for each holding click on a transaction to see JOHN ABALLI's performance on stock
You May Also Like
JOHN ABALLI insider profile FAQ
What is the percentage of profitable transactions made by JOHN ABALLI?
The percentage of profitable transactions made by JOHN ABALLI is 40%.
What is the average return per transaction made by JOHN ABALLI?
The average return per transaction made by JOHN ABALLI is 92.90%.
What stocks does JOHN ABALLI hold?
JOHN ABALLI holds: XGN stocks.
What was JOHN ABALLI’s latest transaction?
JOHN ABALLI latest transaction was an Informative Sell of $375.40K.
What was JOHN ABALLI's most profitable transaction?
JOHN ABALLI’s most profitable transaction was an Informative Buy of XGN stock on November 18, 2024. The return on the trade was 290.60%.
What is JOHN ABALLI's role in Exagen?
JOHN ABALLI's role in Exagen is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.